How Sleep Clinics Now Predict Whether an Oral Appliance Will Work Before You Pay for One
Predicting oral appliance success sleep apnea teams now rely on four real tests, and only some of them are available in Europe
Before you hand over several hundred euros for a custom mandibular device, there are concrete ways to find out whether it will actually work for your airway.
What Predicting Oral Appliance Success Sleep Apnea Testing Involves
Predicting oral appliance success sleep apnea specialists once left to chance is now possible before you spend anything. A clinic can test, in advance, whether a mandibular advancement device (MAD) will lower your apnoea-hypopnoea index (AHI) enough to justify the price. Several of these tests can be booked in Europe today.
Your hesitation is reasonable. Harvard Health Publishing (2021) reports that about 25% of men and nearly 10% of women have obstructive sleep apnoea, and that dental appliances "only work about half the time". Before you sign a quote, it helps to understand whether the extra cost of a custom-fit device is justified for an airway like yours.
Oral appliance therapy (OAT) works by holding the lower jaw forward all night. That advancement pulls the tongue base forward and widens the space behind it. If your airway closes somewhere the jaw cannot influence, the device fails however well it is built.
- Response prediction is a real clinical service, not a theory.
- Baseline severity alone does not tell you whether a splint will work.
- Where your airway collapses matters more than how many events you record.
Responder or Non-Responder Depends on the Definition Used
A responder is not a fixed category. Clinics and studies use at least three different finish lines, and the same patient can pass one while failing another. That single fact explains why quoted success rates swing from roughly half of patients to over ninety percent.
| Success definition | What it means for you | Where you meet it |
|---|---|---|
| AHI below 5 events/hour | Near-complete resolution of breathing events | The strictest definition in use |
| AHI below 10 with symptom relief | Good control, some residual events | A commonly used clinical target |
| 50% AHI reduction | Partial response, you may still need more | The threshold used in the 2020 simulation-bite study |
| Mean disease alleviation | Combines efficacy with hours actually worn | European Respiratory Society framing |
The European Respiratory Society, in its work on non-CPAP therapies, notes that in mild-to-moderate OSA oral appliances reach similar effectiveness to CPAP once mean disease alleviation is measured. That measure rewards a device you actually wear all night.
Ask your clinic two questions before you agree to anything. Which definition of success will be used, and on which test, a full polysomnography or a home sleep apnoea test reporting a respiratory event index (REI).
- Get the success definition in writing before the device is made.
- A 50% AHI reduction from a high baseline can still leave you unwell.
- Track your oxygen desaturation index (ODI) and Epworth Sleepiness Scale (ESS) score too.
Four Methods for Predicting Oral Appliance Success Sleep Apnea Teams Use in Europe
Four practical options exist. Two are clinical tests, one is a cheap real-world trial, and one uses data you may already own.
1Drug-induced sleep endoscopy with a simulation bite
An ENT specialist watches your airway close under light sedation, then advances your jaw to see whether it reopens. In a 2018 study of 40 patients in the Journal of Clinical Sleep Medicine, patients selected using drug-induced sleep endoscopy (DISE) reached 75% treatment success against 50% without it, and 45% versus 15% got below an AHI of 5 events/hour.
2Single-night titration with a remotely controlled positioner
You sleep wearing a temporary motorised device that advances your jaw in steps of roughly 0.2 mm while software watches for flow limitation. Remotely controlled mandibular protrusion (RCMP) titration reported sensitivity 81.8% and specificity 92.9% in Sutherland's 2017 work, cited in the 2022 SLEEP review. Be aware that 8 of 33 tests, about one in four, came back inconclusive.
3A titratable thermoplastic trial device
A low-cost adjustable tray tells you something no scan can, namely whether you tolerate sleeping with your jaw held forward. It proves comfort and early symptom change, never AHI reduction. Treat a good trial as permission to invest in a custom device, then confirm the result with a repeat sleep study.
4Your own CPAP therapeutic pressure
If you have trialled CPAP, your machine already measured how collapsible your airway is. Clinicians in dental sleep medicine often treat a required pressure above roughly 14 cmH2O as a warning sign of likely non-response. It is a rule of thumb rather than a validated threshold, but it costs nothing to check.
You may have read about an at-home auto-adjusting mandibular positioner that predicts response overnight. Published work in the Journal of Clinical Sleep Medicine (2022) reported sensitivity 0.91 and specificity 1.00 in 58 patients, and it identified the efficacious target protrusive position. The catch for European readers is availability. That technology is cleared in North America, and this research found no CE marking and no confirmed European distribution route, so asking for it locally will usually go nowhere.
| Option | What it tells you | European availability | Burden |
|---|---|---|---|
| DISE with simulation bite | Collapse level and whether advancement opens it | ENT departments in France, Belgium, Italy and the Netherlands | Sedated day case |
| Single-night RCMP titration | Responder status plus target protrusive position | Not a routine European service, so ask your sleep centre first | One study night, 1 in 4 inconclusive |
| At-home auto-adjusting positioner | Responder status and target position at home | No CE marking and no confirmed EU route found | Not bookable in the EU |
| Titratable thermoplastic trial | Tolerance and early symptom change only | A realistic EU option through dental sleep medicine | Weeks of self-titration |
| CPAP therapeutic pressure | Red flag for a highly collapsible airway | Already inside your own device data | Free, needs prior CPAP use |
| Nasal stent trial | Whether nasal-level splinting alone eases snoring or mild-to-moderate OSA | Direct EU delivery, no prescription | Low cost, not for severe OSA |
- DISE with a simulation bite is the most widely available predictive test in France, Belgium, Italy and the Netherlands.
- A titration study also gives your jaw its target position, not just a yes or no.
- Do not chase the North American home test, because it has no confirmed European route.
What a Sleep Endoscopy Appointment Is Actually Like
DISE is a short day-case procedure in an ENT department. A doctor gives you propofol or midazolam so you drift into a light drug-induced sleep, then passes a thin flexible endoscope through your nose to film your airway while it collapses. You go home the same day, and you must not drive.
Mid-procedure the team performs a jaw thrust, or inserts a custom simulation bite, a temporary Herbst-type positioner set at your maximum comfortable protrusion. The camera then shows whether advancement genuinely reopens the airway at each level.
The findings that predict success or failure
The favourable signature described in that 2018 Journal of Clinical Sleep Medicine study is increased airway dimension at the velum and oropharynx on jaw thrust, roughly 3 mm or more of opening at the velum, and a clear view of the arytenoids and posterior vocal folds. Tongue base collapse that opens with advancement is the classic responder pattern.
Complete concentric collapse (CCC) at the palate points the other way. When the velopharynx closes like a shutter from every side, moving the jaw forward rarely rescues it. A prospective Italian study published via PMC (2020) used a customised simulation bite in 66 consecutive patients and reported a 91% response rate, with mean AHI falling from 43.10 to 12.93 events/hour and significant widening at the velopharynx, tongue base and epiglottis.
- DISE is sedated, short, and performed as a day case rather than overnight.
- Tongue base collapse that opens on advancement predicts response.
- Complete concentric collapse at the palate predicts appliance failure.
Free Predictors You Can Check Before Booking Anything
Several predictors cost nothing and sit inside reports you already have. A 2025 pilot study in Sleep and Breathing followed 57 patients and found 63.2% were responders after titration while 36.8% were not. Carrying more endotypic traits, meaning severe airway collapsibility, high loop gain or a low arousal threshold, predicted non-response with an odds ratio of 7.24.
The same 2025 model flagged two further variables: a smaller distance between your habitual bite and your maximal retruded position (odds ratio 0.28) and the absence of positional obstructive sleep apnoea (odds ratio 0.94). Those traits belong to your OSA endotype rather than to your severity score.
Severity itself is a poor guide. In work by Jugé and colleagues reported in the 2022 SLEEP review, a model built on polysomnographic airflow features classified 69.2% of patients correctly into response categories at more than 4 mm of advancement, against 50.0% using baseline AHI alone.
Your five-minute self-check
- Positional pattern: do your events cluster while you lie on your back? Positional obstructive sleep apnoea (POSA) changes the calculation.
- Jaw range: how far can you slide your lower jaw forward from your habitual bite? Percentage of maximum protrusion drives the dose.
- Mandibular torus: a bony ridge inside the lower jaw can make a splint hard to seat comfortably.
- Dental state: few teeth, untreated decay or active periodontal disease rule out semi-customised splints under NICE NG202.
- Body weight: a higher BMI is commonly linked with a more collapsible airway and a harder result to achieve.
- CPAP data: note your therapeutic pressure and your residual AHI if you have used a machine.
- Your AHI number alone predicts appliance success barely better than a coin toss.
- Endotype traits, jaw range and body position carry more predictive weight.
- Bring these findings to the consultation, because they shorten the conversation.
How European Reimbursement Rules Change the Decision
Payment rules differ sharply by country, and the American price tags you may have read do not describe Europe at all. Every system routes you through a physician-led sleep pathway before a device is funded.
| Country | Local name | Core rule |
|---|---|---|
| France | Orthèse d'avancée mandibulaire (OAM) | Demande d'accord préalable to the CPAM, with tacit approval if no refusal arrives within 15 days; first-line for an IAH of 15 to 30 without severity signs, second-line after CPAP refusal or intolerance when the IAH exceeds 30; diagnosis by polygraphie ventilatoire or polysomnographie; at least 3 of 6 defined symptoms; only LPPR-listed devices reimbursed |
| Germany | Unterkieferprotrusionsschiene (UKPS) | A statutory benefit after the G-BA decision of 20 November 2020, in force 24 February 2021, with the dental treatment rules in force 30 July 2021; restricted to adults with mild-to-moderate OSA who cannot successfully use mask therapy |
| Belgium | Mandibulair repositieapparaat (MRA) | Funded through the RIZIV/INAMI sleep apnoea convention since 1 January 2017; requires full polysomnography, age 18 or over, and an AHI between 5 and 30 with symptoms, arranged via a recognised sleep centre |
| United Kingdom | Mandibular advancement splint (MAS) | NICE NG202 recommends customised or semi-customised splints for mild, moderate and severe symptomatic OSAHS when CPAP is declined or not tolerated |
Two consequences matter. First, none of the funding criteria above include a predictive test, because entitlement is keyed to your diagnosis, your symptoms and your CPAP status. Second, predictive testing is generally not separately reimbursed, which is the honest reason your dentist never offered you one.
Cost expectations deserve recalibrating too. In France the Sécurité sociale reimburses 60% of the LPPR base tariff for a listed device, or 100% under an ALD, and a mutuelle can cover up to the remaining 40%. The share you actually pay therefore bears little resemblance to the four-figure totals quoted on American consumer pages.
- A predicted non-response does not cancel your reimbursement entitlement.
- In Germany the appliance is second-line, so CPAP failure is the gatekeeper.
- In Belgium a high-street dentist cannot start the process for you.
If the Test Says You Will Probably Not Respond
A predicted non-response is useful information, not a dead end. It spares you the out-of-pocket cost of a device you would never have worn, and it redirects you toward a mechanism that matches your airway. The right next step depends on where your obstruction actually sits.
If your events cluster on your back, positional therapy targets that pattern directly. If your collapse is concentric at the palate, jaw advancement is unlikely to help, and a specialist may discuss surgical or nerve-stimulation options. If nasal-level resistance dominates your snoring, splinting the nasal airway is the mechanism that fits.
That last route is where the Back2Sleep nasal stent belongs. It is a CE-certified Class I soft silicone intranasal stent that keeps the nasal airway open during sleep, sold without prescription, with four sizes in a starter kit at around 39 EUR and a 30-day money-back period. It is intended for snoring and mild-to-moderate obstructive sleep apnoea only. Because it sits in the nose rather than on the teeth, it does not move the jaw, so occlusal change and temporomandibular joint (TMJ) strain are not part of how it works. Our guide to how a nasal stent and a mandibular device suit different snoring types explains which pattern matches which mechanism.
Whatever you choose, close the loop with objective data. Ask for a repeat polygraphie ventilatoire or polysomnography while using the therapy, then compare AHI, oxygen desaturation index and your Epworth score against baseline. Without that follow-up test you only know whether your partner complains less.
- Match the therapy to your collapse pattern, not to the first quote you receive.
- Predicted non-responders should test a cheaper mechanism before committing.
- Always confirm any therapy with a follow-up sleep study, never with impressions alone.
What Back2Sleep Users Say
Frequently Asked Questions
How do I know if a mandibular advancement device will work for me before I pay for one?
Ask your sleep clinic about drug-induced sleep endoscopy with a simulation bite, or a single-night titration study using a remotely controlled mandibular positioner. Both estimate response before a custom device is made. If neither is available locally, a titratable thermoplastic trial device and your recorded CPAP pressure give useful, cheaper signals.
What percentage of people actually respond to an oral appliance for sleep apnoea?
It depends on the definition used. Harvard Health Publishing (2021) says dental appliances work about half the time. A Sleep and Breathing pilot study (2025) found 63.2% of 57 patients responded after titration. A 2020 Italian study published via PMC reported 91%, applying a 50% AHI-reduction threshold.
Does my CPAP pressure tell me whether a mandibular splint will work?
It gives a useful hint. Dental sleep medicine clinicians often treat a therapeutic pressure above roughly 14 cmH2O as a red flag for likely non-response, because it suggests a highly collapsible airway. Treat it as a rule of thumb, not a validated cut-off, and discuss it with your sleep physician.
Can a home sleep apnoea test predict whether an oral appliance will work?
Not on its own, but its data helps. A home sleep apnoea test or polygraphie ventilatoire shows your respiratory event index, oxygen desaturation index and whether events cluster when you lie on your back. Positional obstructive sleep apnoea and airflow-shape analysis both feed modern prediction models used in specialist centres.
Is it worth trying a cheap adjustable mouthpiece before buying a custom-made one?
Often yes, as a tolerance test rather than a treatment. A titratable thermoplastic trial device shows whether you can sleep with your jaw advanced and whether early symptoms improve. It does not prove your AHI fell, so any positive trial should still be confirmed by a repeat sleep study.
Will my insurer still pay if a test suggests I probably will not respond?
In most European systems, funding is keyed to your diagnosis and CPAP status, not to a predictive test. France uses a demande d'accord préalable, Germany restricts the UKPS to CPAP failure, Belgium routes you through a sleep centre convention, and the UK follows NICE NG202. Predictive tests themselves are generally not reimbursed.
How do I get a follow-up sleep study to confirm my oral appliance is working?
Ask for it at fitting, not afterwards. Once your device reaches its target protrusive position, request a repeat polygraphie ventilatoire or polysomnography while wearing it. Compare AHI, oxygen desaturation index and Epworth Sleepiness Scale against baseline. Without that test, you only know your partner hears less snoring.
Ready for quieter nights? Discover the Back2Sleep starter kit and find the right fit for you.
Not sure if you are at risk? Take our sleep risk screening to find out in just a few minutes.
Want to learn how it works? Explore the Back2Sleep nasal stent designed for comfortable, effective relief.